The largest database of trusted experimental protocols

Flp in trex

Manufactured by Thermo Fisher Scientific
Sourced in United Kingdom, Germany, United States

The Flp-In T-Rex system is a gateway-based inducible expression system for generating isogenic stable cell lines in mammalian cells. It allows for the rapid generation of stable cell lines with robust, tetracycline-inducible expression of the gene of interest.

Automatically generated - may contain errors

21 protocols using flp in trex

1

Generating Stable Cell Lines for eGFP Fusion Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human HCT116 colon carcinoma cells and human cervical carcinoma HeLa cells were purchased from American Type Culture Collection (ATCC) and cultured in McCoy’s 5A medium (HCT116) and Dulbecco’s modified Eagle’s medium (HeLa), supplemented with 10% fetal bovine serum and 1.5 mmol/l glutamine. The authenticity of the cell lines was verified at the beginning of the project by short tandem repeat (STR) profiling, in accordance with ATCC product description. Generation of the HeLa Flp In TRex stable cell lines expressing the eGFP-fusion proteins or the short hairpin RNA was performed according to manufacturer’s protocol (Flp In TRex, Invitrogen) and cultured in the presence of appropriate selective antibiotics. Addition of tetracycline (1 μg/ml) induces proteins as described in (11 (link)).
+ Open protocol
+ Expand
2

Inducible RNAi and Affinity Purification of Nuclear Pore Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa Flp-In T-REx cell line 30 (link) was stably transfected with an inducible plasmid expressing EmGFP and a microRNA against the ORF of the Nup358 mRNA using the BLOCK-iT Inducible Pol II miRNA RNAi Expression Vector Kit w/EmGFP from Life Technologies (with a modified Gateway destination vector compatible with the Flp-In system 4 (link)). Cells were treated for 4 days with 1 μg/ml of tetracycline to induce the expression of EmGFP and the miRNA. Isolation and plunge freezing of nuclear envelopes was carried out as previously described 4 (link). All cell lines used in this study have been regularly tested for Mycoplasma contamination but have not been authenticated.
Nup188, Nup205, Nup93, Nup155, Nup85 and Nup62 cDNAs were purchased from the human ORFeome collection, subcloned into a Gateway destination vector with an N-terminal His6-HA-StrepII-tag, and stably transfected into the cell line 293 Flp-In T-REx (Life Technologies). Cells were treated for 8 days with 1 μg/ml of tetracycline to induce the expression of the fusion protein, which was subsequently affinity-purified.
+ Open protocol
+ Expand
3

Inducible RNAi and Affinity Purification of Nuclear Pore Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa Flp-In T-REx cell line 30 (link) was stably transfected with an inducible plasmid expressing EmGFP and a microRNA against the ORF of the Nup358 mRNA using the BLOCK-iT Inducible Pol II miRNA RNAi Expression Vector Kit w/EmGFP from Life Technologies (with a modified Gateway destination vector compatible with the Flp-In system 4 (link)). Cells were treated for 4 days with 1 μg/ml of tetracycline to induce the expression of EmGFP and the miRNA. Isolation and plunge freezing of nuclear envelopes was carried out as previously described 4 (link). All cell lines used in this study have been regularly tested for Mycoplasma contamination but have not been authenticated.
Nup188, Nup205, Nup93, Nup155, Nup85 and Nup62 cDNAs were purchased from the human ORFeome collection, subcloned into a Gateway destination vector with an N-terminal His6-HA-StrepII-tag, and stably transfected into the cell line 293 Flp-In T-REx (Life Technologies). Cells were treated for 8 days with 1 μg/ml of tetracycline to induce the expression of the fusion protein, which was subsequently affinity-purified.
+ Open protocol
+ Expand
4

Generating Chimeric Fluorescent Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chimeric cDNAs encoding the different eGFP- or YFP-tagged proteins were amplified by PCR from already established eGFP/YFP-containing plasmid libraries (Castello et al. 2012 (link)). Alternatively, a HeLa cDNA library and eGFP plasmid were used as templates for fusion PCR. Resulting chimeric cDNAs were cloned into pCDNA5/FRT/TO (Life Technologies). HeLa cell lines were established as described in the manufacturer's protocols (Flp-In TRex, Life Technologies).
+ Open protocol
+ Expand
5

Stable HeLa Cell Line Generation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Semi-confluent Flp-In™ T-REx™ (Life Technologies) HeLa cells (grown on 10 cm dish) were transfected with 1.5 mg of pOG44 plasmid and 0.4 mg of constructs pcDNA5/FRT/TO/RBM7–3xC-Flag or pcDNA5/FRT/TO/F13A-3xC-Flag, respectively using TURBOFECT (Fermentas) following the manufacturer's instructions. Cells with stably integrated constructs were selected in the presence of hygromycin B and blasticidin according to manufacturers instructions. Cells were cultivated until visible colonies appeared on the plate. Several clones were picked and tested for the Zeocin sensitivity and expression of the protein.
+ Open protocol
+ Expand
6

Chimeric TRAP1-GFP Expression in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chimeric cDNA encoding the different eGFP-tagged TRAP1 was amplified by PCR from already established eGFP-containing-plasmid libraries17 (link). Resulting chimeric cDNA was cloned into pCDNA5/FRT/TO (Life Technologies). HeLa cell line expressing TRAP1-GFP was established as described in the manufacturer’s protocols (Flp-In TRex, Life Technologies). Parental HeLa Flp-In TRex and HeLa cell line expressing unfused GFP were a kind gift from Matthias Hentze.
GT1 and HeLa cells were grown in Dulbecco’s modified Eagle’s medium (DMEM), with 4500 mg/glucose/L, 110 mg sodium pyruvate and L-glutamine (SIGMA D6429), supplemented with 10% fetal bovine serum. SH-SY5Y were grown in RPMI-1640 (Euroclone), with 4500 mg/glucose/L, 110 mg sodium pyruvate and L-glutamine, supplemented with 10% fetal bovine serum. Cells were cultured at 37 °C under 5% CO2. Proteasomal block was performed with 150 μM ALLN for 7 hours in complete medium. Methyl-β-cyclodextrin (βCD) treatment was carried out as described elsewhere18 (link). Briefly, GT1 or SH-SY5Y cells were plated on dishes and cholesterol depleted by βCD (10 mM) that was added to the medium containing 20 mM HEPES, pH 7.5, and 0.2% bovine albumin for 1 h at 37 °C.
+ Open protocol
+ Expand
7

Stable cell lines expressing bestrophin 1

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Flp-in T-Rex system (Life Technologies, Paisley, UK) was used to generate stable MDCKII cell lines expressing wild-type, BVMD (p.L234V and p.N296S), and ARB (p.M325T) bestrophin 1. A reverse transfection protocol was used to improve the transfection efficiency. Bestrophin 1 constructs in pcDNA5/FRT/TO were cotransfected with pOG44 into MDCKII Flp-in T-Rex host cells using Lipofectamine LTX and Plus reagent (Life Technologies). Cells were selected with 400 µg/mL hygromycin and 4 µg/mL blasticidin for 2 weeks.
+ Open protocol
+ Expand
8

Ciliary formation and disruption in RPE-1 and HEK293T cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
RPE-1 Flp-In T-Rex (a gift from Erich Nigg) and TTBK2 KO cells and RPE1 WT were grown in DMEM F12 (Thermo Fisher Scientific, 11320033) supplemented by 10% fetal bovine serum (FBS), 1% penicillin/streptomycin, and 1% l-glutamine, HEK293T wt, and TTBK2 KO Flp-In T-Rex (Thermo Fisher Scientific, R78007) cells were grown in DMEM Glutamax (Thermo Fisher Scientific, 10569069) supplemented by 10% FBS and 1% penicillin/streptomycin. Transfection of RPE1 was carried out by Lipofectamine 3000 (Invitrogen) according to manufacturer’s instructions (up to 0.5 µg DNA per condition/well, 24-well plate format). HEK293T were transfected by Polyethyleneimine (PEI) as follows: PEI was incubated in DMEM for 10 min and then mixed with plasmid equilibrated in DMEM in ratio 3 µl PEI/1 µg plasmid; the mixture was incubated for 15 min and then added to cells. Growth medium was changed 4 h after transfection. To induce formation of PC, 24 h following the transfection, RPE-1 cells were starved by serum-free medium for 24 h to assess ciliogenesis or ON for TTBK2 removal measurement. Centrinone (150 µM) (Wong et al., 2015 ) treatment was carried out for 72 h. Cytochalasine (2 µM) (Merck, Sigma Aldrich, C8273) and Nocodazole (100 ng/ml) (Merck, Sigma-Aldrich, M1404) treatment was carried out overnight.
+ Open protocol
+ Expand
9

NTHL1 Interactome Mapping via BioID

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human NTHL1 was cloned into pcDNA5 FRT/ FLAGBirA* vector. Using the Flp-In™ T-REx™ system (Thermofisher), we generated 293 TRE Flp-In cells stably expressing NTHL1-BirA*-FLAG, eGFP-NLS-BirA*-FLAG, and eGFP-BirA*-FLAG under a tetracycline inducible system. Cells were treated with 1 μg/ml of tetracycline for 24 h to induce protein expression. Six hours before cell collection, 50 μM of biotin were added and immediately followed by irradiation treatment. BioID purification and mass spectrometry data acquisition and analysis were performed as described (47 (link)).
+ Open protocol
+ Expand
10

Recombinant hResistin Protein Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
We produced recombinant hResistin protein in our laboratory using a mammalian cell expression system. C-terminal FLAG-tagged hResistin and mouse RELMα were generated by PCR, inserted into pcDNA5/FRT/TO vector, and then integrated in a Flp recombinase-dependent manner into the genome of the Flp-In™ T-Rex™ 293 cell line using the Flp-In™ T-Rex™ kit from Invitrogen as we have described (4 (link)). Production of these recombinant proteins was induced by adding tetracycline (1 μg/ml) to the cell culture media. hResistin was purified by anti-FLAG M2 antibody agarose (A2220, Sigma) column chromatography from the 293-cell culture medium with FLAG (0.1 mg/ml) elution. Presence of the protein was determined by SDS-PAGE gel Coomassie staining, and concentration of the protein in the elution was determined by the Bio-Rad Protein Assay. Activity assays were performed on each lot of protein purified. After being serum starved, human (h) PASMCs were treated with 100 nM recombinant hResistin, whereas 3T3 mouse embryonic fibroblasts were treated with the same dosage of recombinant RELMα, all for 15 min. Then cells were collected, lysed, and processed for western blotting. Activity of the purified RELM proteins was tested by assaying their ability to induce Akt phosphorylation (4 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!